Navigating the NASH Maze
The availability of 2 approved medicines for the treatment of idiopathic pulmonary fibrosis (IPF) has stimulated an explosion in fibrosis research and in the search for new anti-fibrotic agents. Nowhere is this more evident than in the field of non-alcoholic steatohepatitis (NASH). While there have been multiple review articles covering NASH of late, TherapeutAix is […]
TherapeutAix present at The Society for Medicines Research meeting
The Society for Medicines Research (SMR) is holding a meeting on 26th September 2018 in Stevenage titled, ‘The Best of Both Worlds: Innovation, Collaboration and Synergy between CROs and their Client Partners.’ The meeting will showcase innovation in science that has emerged from successful Client-CRO partnerships which have moved beyond fee-for-service agreements, towards much broader […]